middle.news
How Bio-Gene’s US DoD Grants and OMRI Approval Could Transform Insecticide Markets
8:44am on Friday 30th of January, 2026 AEDT
•
Agriculture
Read Story
How Bio-Gene’s US DoD Grants and OMRI Approval Could Transform Insecticide Markets
8:44am on Friday 30th of January, 2026 AEDT
Key Points
Advancement of Flavocide® wearable device and Qcide® indoor spray projects under US DoD grants
Qcide® gains OMRI approval for use in US organic agriculture
Pilot-scale manufacturing scale-up achieved with Rallis India for Flavocide®
Received $519,500 R&D tax incentive from Australian government
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Bio-Gene Technology (ASX:BGT)
OPEN ARTICLE